Lineage Cell Therapeutics (LCTX) Gross Profit (2011 - 2026)
Lineage Cell Therapeutics (LCTX) posted quarterly Gross Profit of $1.7 million for Q1 2026, up 17.67% year-over-year from $1.5 million in Q1 2025, and down 73.63% quarter-over-quarter from $6.5 million in Q4 2025.
Lineage Cell Therapeutics (LCTX) Gross Profit (2011 - 2026) Analysis & Trends
Lineage Cell Therapeutics' Gross Profit history runs 16 years deep, the most recent figure standing at $1.7 million for Q1 2026.
- In Q1 2026, Gross Profit rose 17.67% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $14.7 million (up 57.99% YoY), while the FY2025 annual figure was $14.4 million, up 57.23% from the prior year.
- Gross Profit for Q1 2026 stood at $1.7 million, down from $6.5 million in the prior quarter.
- The five-year high for Gross Profit was $6.5 million in Q4 2025, with the low at $1.1 million in Q3 2023.
- The 5-year median for Gross Profit is $2.7 million (2024), against an average of $2.8 million.
- The sharpest annual moves came in 2022 and 2023: Gross Profit surged 1713.98% in 2022, then plunged 61.02% in 2023.
- Lineage Cell Therapeutics' Gross Profit stood at $1.8 million in 2022, then gained by 1.05% to $1.8 million in 2023, then jumped by 48.14% to $2.7 million in 2024, then jumped by 141.05% to $6.5 million in 2025, then plunged by 73.63% to $1.7 million in 2026.
- Business Quant data shows LCTX's Gross Profit at $1.7 million in Q1 2026, $6.5 million in Q4 2025, and $3.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Lineage Cell Therapeutics | 270.61 Mn | 212.77 Mn | 1.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.07 Mn |
| Jun 30, 2026 | 1.07 Mn |
| Mar 31, 2026 | 1.73 Mn |
| Mar 31, 2026 | 1.73 Mn |
| Dec 31, 2025 | 6.54 Mn |
| Dec 31, 2025 | 6.54 Mn |
| Sep 30, 2025 | 3.68 Mn |
| Sep 30, 2025 | 3.68 Mn |
| Jun 30, 2025 | 2.73 Mn |
| Jun 30, 2025 | 2.73 Mn |
| Mar 31, 2025 | 1.47 Mn |
| Mar 31, 2025 | 1.47 Mn |
| Dec 31, 2024 | 2.71 Mn |
| Dec 31, 2024 | 2.71 Mn |
| Sep 30, 2024 | 3.74 Mn |
| Sep 30, 2024 | 3.74 Mn |
| Jun 30, 2024 | 1.36 Mn |
| Jun 30, 2024 | 1.36 Mn |
| Mar 31, 2024 | 1.35 Mn |
| Mar 31, 2024 | 1.35 Mn |